
Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated August 12, 2026, titled " Unaudited (standalone and consolidated) financial results of the Company for quarter ended June 30, 2026".
Filed with NSE · · 3 pages · English
Suraksha Diagnostic Ltd. has released its unaudited financial results for the first quarter of the fiscal year, highlighting strong performance compared to the previous year. The company reported significant growth in profit after tax and EBITDA, indicating a robust operational performance. Joint Managing Director & CEO Ritu Mittal commented on the healthy growth in both patient and test volumes, reflecting strong consumer demand. Suraksha continues to expand its network, aligning with its strategy to enhance market presence and operational density.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Suraksha Diagnostic's latest callSuraksha Diagnostic (NSE:SURAKSHA) Q1 2027 Earnings Call · Replay · Aug 13Read the transcript of Suraksha Diagnostic (NSE:SURAKSHA) Q1 2027 Earnings Call
Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated August 12, 2026, titled " Unaudited (standalone and consolidated) financial results of the Company for quarter ended June 30, 2026".
Suraksha Diagnostic Ltd. on 6ix
Follow Suraksha Diagnostic into a list and get an email when it puts out news.
Follow Suraksha Diagnostic